New Delhi [India], July 23 (ANI): An expert group of the Indian government is in talks with global pharma major Pfizer over COVID vaccine supply, said Union Health Minister Mansukh Mandaviya on Friday.
New Delhi [India], July 9 (ANI): The Government of India is holding discussions with COVID-19 vaccine manufacturers Moderna and Pfizer over several issues including indemnity waiver, said Dr V K Paul, Member (Health), NITI Aayog on Friday.
New Delhi [India], July 6 (ANI): The Indian drug regulator has urged Pfizer twice in writing to apply for emergency use authorization for its COVID-19 vaccine so that the application is processed well in time but Pfizer has not applied for the license yet, said sources on Tuesday.
Washington [US], June 18 (ANI/Sputnik): Canada's National Advisory Committee on Immunizations (NACI) is recommending those who received the Oxford-AstraZeneca coronavirus shot as the first dose in their vaccination schedule to get vaccinated with a messenger RNA (mRNA) vaccine for their second dose.
New Delhi [India], June 8 (ANI): Even as Pfizer's Covid vaccine has being authorised for use in children in the US and parts of Europe, Dr VK Paul, Member-Health at Niti Aayog said that approval to the coronavirus vaccines of Pfizer and Moderna is under consideration in India.
New Delhi [India], June 3 (ANI): Amid discussions over possible legal protection to foreign vaccine manufacturers Pfizer and Moderna over their COVID-19 jabs in India, the Serum Institute of India (SII) has also sought protection against liabilities, sources said on Thursday.
New Delhi [India], May 27 (ANI): Pfizer on Wednesday said it continues to remain engaged with the Indian government towards making its coronavirus vaccine available for use in the government immunisation programme.